Neurosteroids and their role in sex-specific epilepsies

Neurobiology of Disease

Volumn 72, Issue PB, 2014, Pages 198-209

  Reddy, Doodipala Samba ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Allopregnanolone; Catamenial epilepsy; GABA A receptor; Neurosteroid; Progesterone

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3ALPHA,21 DIHYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ANDROSTANOLONE; ANDROSTENEDIOL; DEOXYCORTICOSTERONE; DIHYDRODEOXYCORTICOSTERONE; ESTROGEN; NEUROSTEROID; PROGESTERONE; TESTOSTERONE; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ANTICONVULSANT ACTIVITY; BRAIN FUNCTION; BRAIN REGION; CATAMENIAL EPILEPSY; DISEASE ASSOCIATION; EPILEPTOGENESIS; GABAERGIC TRANSMISSION; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; INHIBITION KINETICS; MENOPAUSE; MENSTRUAL CYCLE; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SEIZURE SUSCEPTIBILITY; SEX DIFFERENCE; STEROIDOGENESIS; EPILEPSY; FEMALE; MALE; METABOLISM; PHYSIOLOGY; SEXUAL DEVELOPMENT;

EPILEPSY; FEMALE; HUMANS; MALE; MENSTRUAL CYCLE; NEUROTRANSMITTER AGENTS; RECEPTORS, GABA-A; SEX CHARACTERISTICS;

EID: 84909951509     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.06.010     Document Type: Review

References (141)

1. Abassi F., Krumholz A., Kittner S.J., Langenberg P. Effects of menopause on seizures in women with epilepsy. Epilepsia 1999, 42:205-210.
2. Agís-Balboa R.C., Pinna G., Zhubi A., Maloku E., Veldic M., Costa E., Guidotti A. Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:14602-14607.
3. A receptors. Psychoneuroendocrinology 2009, 34S:S59-S66.
4. Alves S.E., McEwen B.S., Hayashi S., Korach K.S., Pfaff D.W., Ogawa S. Estrogen-regulated progestin receptors are found in the midbrain raphe but not hippocampus of estrogen receptor alpha (ER-alpha) gene-disrupted mice. J. Comp. Neurol. 2000, 427:185-195.
5. Auger C.J., De Vries G.J. Progestin receptor immunoreactivity within steroid-responsive vasopressin-immunoreactive cells in the male and female rat brain. J. Neuroendocrinol. 2002, 14:561-567.
6. Bäckström T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol. Scand. 1976, 54:321-347.
7. Bäckström T., Zetterlund B., Blom S., Romano M. Effect of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol. Scand. 1984, 69:240-248.
8. Bauer J. Interactions between hormones and epilepsy in female patients. Epilepsia 2001, 42(Suppl. 3):20-22.
9. Bauer J., Burr W., Elger C.E. Seizure occurrence during ovulatory and anovulatory cycles in patients with temporal lobe epilepsy: a prospective study. Eur. J. Neurol. 1998, 5:83-88.
10. Baulieu E.-E. Steroid hormones in the brain: several mechanisms?. Steroid Hormone Regulation of the Brain 1981, 3-14. Pergamon Press, Oxford. F. Fuxe, J.A. Gustafsson, L. Wetterberg (Eds.).
11. Bazan A.C., Montenegro M.A., Cendes F., Min L.L., Guerreiro C.A. Menstrual cycle worsening of epileptic seizures in women with symptomatic focal epilepsy. Arg. Neuro-Psiquiatria. 2005, 63(3B):751-756.
12. Belelli D., Bolger M.B., Gee K.W. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur. J. Pharmacol. 1989, 166:325-329.
13. A receptors. Neuropharmacology 2002, 43:651-661.
14. Biagini G., Baldelli E., Longo D., Pradelli L., Zini I., Rogawski M.A., Avoli M. Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp. Neurol. 2006, 201:519-524.
15. Biagini G., Longo D., Baldelli E., Zoli M., Rogawski M.A., Bertazzoni G., Avoli M. Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period. Epilepsia 2009, 50(Suppl. 1):53-58.
16. Biagini G., Panuccio G., Avoli M. Neurosteroids and epilepsy. Curr. Opin. Neurol. 2010, 23:170-176.
17. Bianchi M.T., Macdonald R.L. Neurosteroids shift partial agonist activation of GABA-A receptor channels from low- to high-efficacy gating patterns. J. Neurosci. 2003, 23(34):10934-10943.
18. Bonuccelli U., Melis G.B., Paoletti A.M., Fioretti P., Murri L., Muratorio A. Unbalanced progesterone and estradiol secretion in catamenial epilepsy. Epilepsy Res. 1989, 3:100-106.
19. Brinton R.D., Thompson R.F., Foy M.R., Baudry M., Wang J., Finch C.E., Morgan T.E., Pike C.J., Mack W.J., Stanczyk F.Z., Nilsen J. Progesterone receptors: form and function in brain. Front. Neuroendocrinol. 2008, 29:313-339.
20. Carver C.M., Reddy D.S. Neurosteroid interactions with synaptic and extrasynaptic GABA-A receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology 2013, 230(2):151-188.
21. Carver C.M., Wu X., Gangisetty O., Reddy D.S. Perimenstrual-like hormonal regulation of extrasynaptic δ-containing GABA-A receptors mediated tonic inhibition and neurosteroid sensitivity. J. Neurosci. 2014, (in press).
22. A receptor modulation: evidence for a low-affinity interaction. J. Neurophysiol. 2009, 102:1254-1264.
23. A receptors. Trends Neurosci. 2010, 33:299-306.
24. Christensen J., Kjeldsen M.J., Anderson H., Friis M.L., Sidenius P. Gender differences in epilepsy 2005, 46:956-960.
25. Clarke R.S., Dundee J.W., Carson I.W. Proceedings: a new steroid anaesthetic-althesin. Proc. R. Soc. Med. 1973, 66:1027-1030.
26. Compagnone N.A., Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 2000, 21(1):1-56.
27. Craig C.R. Anticonvulsant activity of steroids: separability of anticonvulsant from hormonal effects. J. Pharmacol. Exp. Ther. 1966, 153:337-343.
28. A receptors to neuroactive steroids in rats during ethanol withdrawal. J. Pharmacol. Exp. Ther. 1996, 278:510-517.
29. Do Rego J.L., Seong J.Y., Burel D., Leprince J., Luu-The V., Tsutsui K., Tonon M.C., Pelletier G., Vaudry H. Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front. Neuroendocrinol. 2009, 30:259-301.
30. Edwards H.E., Mo V., Burnham W.M., MacLusky N.J. Gonadectomy unmasks an inhibitory effect of progesterone on amygdala kindling in male rats. Brain Res. 2001, 889:260-263.
31. El-Khayat H.A., Soliman N.A., Tomoum H.Y., Omran M.A., El-Wakad A.S., Shatla R. Reproductive hormonal changes and catamenial pattern in adolescent females with epilepsy. Epilepsia 2008, 49:1619-1626.
32. A receptors. Nat. Rev. 2005, 6:215-229.
33. Frye C.A. The neuroactive steroid 3α,5α-THP has anti-seizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 1995, 696:113-120.
34. Frye C.A., Bayon L.E. Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3 alpha,5 alpha-THP. Neuroendocrinology 1998, 68:272-280.
35. Frye C.A., Scalise T.J., Bayon L.E. Finasteride blocks the reduction in ictal activity produced by exogenous estrous cyclicity. J. Neuroendocrinol. 1998, 10:291-296.
36. 4-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway. Neuroscience 2010, 170:865-880.
37. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., McEwen B.S. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther. 1988, 246:803-812.
38. Gilad R., Sadeh M., Rapoport A., Dabby R., Lampl Y. Lamotrigine and catamenial epilepsy. Seizure 2008, 17:531-534.
39. A receptors: views from outside the synaptic cleft. Neuron 2007, 56:763-770.
40. Gowers W.R. Epilepsy and Other Chronic Convulsive Diseases. Their Causes, Symptoms, and Treatment 1881, 197. J & A Churchill, London.
41. Harden C.L. Hormone replacement therapy: will it affect seizure control and AED levels?. Seizure 2008, 17(2):176-180.
42. Harden C.L., Pulver M.C., Ravdin L., Jacobs A.R. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999, 40:1402-1407.
43. Harden C.L., Herzog A.G., Nikolov B.G., Koppel B.S., Christos P.J., Fowler K., Labar D.R., Hauser W.A. Hormone replacement therapy in women with epilepsy: a randomized, double-blind placebo-controlled study. Epilepsia 2006, 47:1447-1451.
44. Harrison N.L., Simmonds M.A. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 1984, 323:287-292.
45. A receptor complex. J. Pharmacol. Exp. Ther. 1987, 241:346-353.
46. Hauser W.A. Incidence and prevalence. Epilepsy: A Comprehensive Textbook 1997, 47-57. Lippincott-Raven Publishers, Philadelphia. J. Engel, T.A. Pedley (Eds.).
47. Herzog A.G. Is there a lateralized asymmetry in the sensitivity of the brain to hormones in epilepsy?. Epilepsy Behav. 2007, 11:157-159.
48. Herzog A.G. Hormonal therapies: progesterone. Neurotherapeutics 2009, 6:383-391.
49. Herzog A.G., Fowler K.M., Smithson S.D., the Progesterone Trial Study Group Progesterone versus placebo therapy for women with epilepsy: a randomized clinical trial. Neurology 2014, 78:1959-1966.
50. Herzog A.G., Klein P., Ransil B.J. Three patterns of catamenial epilepsy. Epilepsia 1997, 38:1082-1088.
51. Herzog A.G., Friedman M.N., Freund S., Pascual-Leone A. Transcranial magnetic stimulation evidence of a potential role for progesterone in the modulation of premenstrual corticocortical inhibition in a woman with catamenial seizure exacerbation. Epilepsy Behav. 2001, 2:367-369.
52. Herzog A.G., Harden C.L., Liporace J., Pennell P., Schomer D.L., Sperling M., Fowler K., Nikolov B., Shuman S., Newman M. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann. Neurol. 2004, 56:431-434.
53. Herzog A.G., Fowler K.M., The NIH Progesterone Trial Study Group. Sensitivity and specificity of the association between catamenial seizure patterns and ovulation. Neurology 2008, 70:486-487.
54. A receptors through two discrete transmembrane sites. Nature 2006, 444:486-489.
55. A receptors. Pharmacol. Ther. 2007, 116:7-19.
56. A receptors. Neuropharmacology 2009, 56:149-154.
57. Jacono J.J., Robinson J. The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle in epileptic women. Epilepsia 1987, 28:571-577.
58. Kaminski R.M., Livingood M.R., Rogawski M.A. Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia 2004, 45:864-877.
59. Kaminski R.M., Marini H., Kim W.J., Rogawski M.A. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia 2005, 46:819-827.
60. Kaplan P.W., Norwitz E.R., Ben Menachem E., Pennell P.B., Druzin M., Robinson J.N., Gordon J.C. Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav. 2007, 11:283-291.
61. Kato J., Hirata S., Nozawa A., Yamada-Mouri N. Gene expression of progesterone receptor isoforms in the rat brain. Horm. Behav. 1994, 28:454-463.
62. Kim G.H., Lee H.W., Park H., Lee S.K., Lee S.A., Kim Y.I., Song H.K., Shin D.J., Hong S.B. Seizure exacerbation and hormonal cycles in women with epilepsy. Epilepsy Res. 2010, 90(3):214-220.
63. Kokate T.G., Svensson B.E., Rogawski M.A. Anticonvulsant activity of neuroactive steroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther. 1994, 270:1223-1229.
64. Kokate T.G., Yamaguchi S., Pannell L.K., Rajamani U., Carroll D.M., Grossman A.B., Rogawski M.A. Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice. J. Pharmacol. Exp. Ther. 1998, 287:553-558.
65. Kulkarni S.K., Reddy D.S. Neurosteroids: a new class of neuromodulators. Drugs Today 1995, 31:433-455.
66. Lambert J.J., Cooper M.A., Simmons R.D., Weir C.J., Belelli D. Neurosteroids: endogenous allosteric modulators of GABA-A receptors. Psychoneuroendocrinology 2009, 34(Suppl. 1):S48-S58.
67. Landgren S., Bäckström T., Kalistratov G. The effect of progesterone on the spontaneous interictal spike evoked by the application of penicillin to the cat's cerebral cortex. J. Neurol. Sci. 1978, 36:119-133.
68. Lawrence C., Martin B.S., Sun C., Williamson J., Kapur J. Endogenous neurosteroid synthesis modulates seizure frequency. Ann. Neurol. 2010, 67:689-693.
69. Li X., O'Malley B.W. Unfolding the actions of progesterone receptors. J. Biol. Chem. 2003, 278:39261-39264.
70. Logothetis J., Harner R., Morrel F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology 1959, 9:352-360.
71. Maguire J., Mody I. Neurosteroid synthesis-mediated regulation of GABA-A receptors: relevance to the ovarian cycle and stress. J. Neurosci. 2007, 27(9):2155-2162.
72. A receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat. Neurosci. 2005, 8:797-804.
73. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986, 232(4753):1004-1007.
74. Mihalek R.M., Banerjee P.K., Korpi E.R., Quinlan J.J., Firestone L.L., Mi Z.P., Lagenaur C., Tretter V., Sieghart W., Anagnostaras S.G., Sage J.R., Fanselow M.S., Guidotti A., Spigelman I., Li Z., DeLorey T.M., Olsen R.W., Homanics G.E. Attenuated sensitivity to neuroactive steroids in γ-aminobutyrate type A receptor δ subunit knockout mice. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:12905-12910.
75. Mitchell S.J., Silver R.A. Shunting inhibition modulates neuronal gain during synaptic excitation. Neuron. 2003, 383:433-445.
76. Monaghan E.P., Navalta L.A., Shum L., Ashbrock D.W., Lee D.A. Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity. Epilepsia 1999, 38:1026-1031.
77. Moran M.H., Smith S. Progesterone withdrawal I: pro-convulsant effects. Brain Res. 1998, 807:84-90.
78. Murphy D.D., Cole N.B., Greenberger V., Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 1998, 18:2550-2559.
79. Niijima S., Wallace S.J. Effects of puberty on seizure frequency. Dev. Med. Child Neurol. 1989, 31:174-180.
80. Nothdurfter C., Rammes G., Baghai T.C., Schüle C., Schumacher M., Papadopoulos V., Rupprecht R. TSPO (18kDa) as a target for novel anxiolytics with a favourable side-effect profile. J. Neuroendocrinol. 2014, 24(1):82-92.
81. Parsons B., Rainbow T.C., MacLusky N.J., McEwen B.S. Progestin receptor levels in rat hypothalamic and limbic nuclei. J. Neurosci. 1982, 2:1446-1452.
82. Peng Z., Huang C.S., Stell B.M., Mody I., Houser C.R. Altered expression of the δ subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy. J. Neurosci. 2004, 24:8629-8639.
83. Pennell P.B. Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?. Epilepsia 2008, 49(Suppl. 9):43-55.
84. A receptor subunit composition?. Receptors Channels 1993, 1:135-142.
85. Quigg M., Smithson S.D., Fowler K.M., Sursal T., Herzog A.G., the Progesterone Trial Study Group Laterality and location influence catamenial seizure expression in women with partial epilepsy. Neurology 2009, 73:223-227.
86. Quigg M., Smithson S.D., Fowler K.M., Sursal T., Herzog A.G. NIH Progesterone Trial Study Group: laterality and location influence catamenial seizure expression in women with partial epilepsy. Neurology 2009, 73(3):223-227.
87. Ramakrishnan L., Hess G.P. Mechanism of potentiation of a dysfunctional epilepsy-linked mutated GABA-A receptor by a neurosteroid (3alpha, 21-dihydroxy-5alpha-pregnan-20-one): transient kinetic investigations. Biochemistry 2010, 49(36):7892-7901.
88. Ramanathan G., Reddy D.S. Inhibition of endogenous neurosteroids accelerates limbic epileptogenesis. Epilepsy Curr. 2011, 2(Suppl. 1). Abst. 1.022.
89. Reddy D.S. Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions?. Trends Pharmacol. Sci. 2003, 24:103-106.
90. Reddy D.S. Anticonvulsant activity of the testosterone-derived neurosteroid 3α-androstanediol. Neuroreport 2004, 15:515-518.
91. Reddy D.S. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3α-androstanediol and 17β-estradiol. Neuroscience 2004, 129:195-207.
92. Reddy D.S. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res. 2009, 85:1-30.
93. Reddy D.S. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog. Brain Res. 2010, 186:113-137.
94. Reddy D.S. Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy. Front. Endocrinol. 2011, 2(38):1-11.
95. Reddy D.S. Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy. Front. Endocrinol. 2011, 2:38.
96. Reddy D.S. Neuroendocrine aspects of catamenial epilepsy. Horm. Behav. 2013, 63:254-266.
97. Reddy D.S. Role of hormones and neurosteroids in epileptogenesis. Front. Cell. Neurosci. 2013, 7:1-20. (article 115).
98. Reddy D.S. Role of hormones and neurosteroids in epileptogenesis. Front Cell Neurosci. 2013, 31(7):115. (Jul).
99. A receptors. J. Pharmacol. Exp. Ther. 2010, 334:1031-1041.
100. Reddy D.S., Mohan A. Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors. J. Neurosci. 2011, 31:650-658.
101. Reddy D.S., Mohan A. Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors. J. Neurosci. 2011, 31(2):650-658.
102. Reddy D.S., Ramanathan G. Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis. Epilepsy Behav. 2012, 25:92-97.
103. Reddy D.S., Rogawski M.A. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy. J. Pharmacol. Exp. Ther. 2000, 294:909-915.
104. Reddy D.S., Rogawski M.A. Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J. Pharmacol. Exp. Ther. 2000, 295:1241-1248.
105. Reddy D.S., Rogawski M.A. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 2001, 42:303-310.
106. A receptor function and seizure susceptibility. J. Neurosci. 2002, 42:3795-3805.
107. Reddy D.S., Rogawski M.A. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 2009, 6:392-401.
108. Reddy D.S., Woodward R. Ganaxolone: a prospective overview. Drugs Future 2004, 29:227-242.
109. Reddy D.S., Zeng Y.C. Effect of neurosteroid withdrawal on spontaneous recurrent seizures in a rat model of catamenial epilepsy. FASEB J. 2007, 21(6):A1179-A11179.
110. Reddy D.S., Kim H.Y., Rogawski M.A. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 2001, 42:328-336.
111. Reddy D.S., Castaneda D.C., O'Malley B.W., Rogawski M.A. Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J. Pharmacol. Exp. Ther. 2004, 310(1):230-239.
112. Reddy D.S., Gangisetty O., Briyal S. Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis. Neuropharmacology 2010, 59(7-8):573-581.
113. Reddy D.S., Gould J., Gangisetty O. A mouse kindling model of perimenstrual catamenial epilepsy. J. Pharmacol. Exp. Ther. 2012, 341:784-793.
114. Rosciszewska D. Epilepsy and menstruation. Epilepsy 1987, 373-381. Chapman & Hall, London. A. Hopkins (Ed.).
115. Roste L.S., Tauboll E., Svalheim S., Gjerstad L. Does menopause affect the epilepsy?. Seizure 2008, 17:172-175.
116. Rudick C.N., Woolley C.S. Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J. Neurosci. 2001, 21:6532-6543.
117. Rupprecht R., Rammes G., Eser D., Baghai T.C., Schüle C., Nothdurfter C., Troxler T., Gentsch C., Kalkman H.O., Chaperon F., Uzunov V., McAllister K.H., Bertaina-Anglade V., La Rochelle C.D., Tuerck D., Floesser A., Kiese B., Schumacher M., Landgraf R., Holsboer F., Kucher K. Translocator protein (18kD) as target for anxiolytics without benzodiazepine-like side effects. Science 2009, 325(5939):490-493.
118. Saalmann Y.B., Kirkcaldie M.T., Waldron S., Calford M.B. Cellular distribution of the GABA-A receptor-modulating 3α-hydroxy, 5α-reduced pregnane steroids in the adult rat brain. J. Neuroendocrinol. 2007, 19:272-284.
119. Scharfman H.E., MacLusky N.J. The influence of gonadal hormones on neuronal excitability, seizures and epilepsy in the female. Epilepsia 2006, 47:1423-1440.
120. Selye H. Anesthetics of steroid hormones. Proc. Soc. Exp. Biol. Med. 1941, 46:116-121.
121. Selye H. The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (metrazol). J. Lab. Clin. Med. 1942, 27:1051-1053.
122. Shen H., Sabaliauskas N., Sherpa A., Fenton A.A., Stelzer A., Aoki C., Smith S.S. A critical role for alpha4betadelta GABA-A receptors in shaping learning deficits at puberty in mice. Science 2010, 327(5972):1515-1518.
123. Smith S.S., Waterhouse B.D., Woodward D.J. Locally applied estrogens potentiate glutamate-evoked excitation of cerebellar Purkinje cells. Brain Res. 1988, 475:272-282.
124. Smith S.S., Gong Q.H., Hsu F.C., Markowitz R.S., ffrench-Mullen J.M.H., Li X. GABA-A receptor α4-subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998, 392:926-930.
125. Smith S.S., Shen H., Gong Q.H., Zhou X. Neurosteroid regulation of GABA-A receptors: focus on the alpha4 and delta subunits. Pharmacol. Ther. 2007, 116:58-76.
126. A-receptor δ subunit. Epilepsia 2002, 43(Suppl. 5):3-8.
127. A receptors. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14439-14444.
128. Stoffel-Wagner B., Beyenburg S., Watzka M.S., Blumcke I., Bauer J., Schramm J., Bidlingmaier F., Elger C.E. Expression of 5α-reductase and 3α-hydroxysteroid oxidoreductase in the hippocampus of patients with chronic temporal lobe epilepsy. Epilepsia 2000, 41:140-147.
129. Stoffel-Wagner B., Watzka M., Steckelbroeck S., Ludwig M., Clusmann H., Bidlingmaier F., Casarosa E., Luisi S., Elger C.E., Beyenburg S. Allopregnanolone serum levels and expression of 5α-reductase and 3α-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy. Epilepsy Res. 2003, 54:11-19.
130. A receptors in an animal model of epilepsy. J. Neurosci. 2007, 27:12641-12650.
131. Tsuda M., Suzuki T., Misawa M. Modulation of the decrease in the seizure threshold of pentylenetetrazole in diazepam-withdrawn mice by the neuroactive steroid 5α-pregnan-3α,21-diol-20-one (alloTHDOC). Addict. Biol. 1997, 2:455-460.
132. Tuveri A., Paoletti A.M., Orrù M., Melis G.B., Marotto M.F., Zedda P., Marrosu F., Sogliano C., Marra C., Biggio G., Concas A. Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy. Epilepsia 2008, 49:1221-1229.
133. A receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J. Physiol. 1992, 456:215-245.
134. Velísková J., Velísek L. Beta-estradiol increases dentate gyrus inhibition in female rats via augmentation of hilar neuropeptide-Y. J. Neurosci. 2007, 27:6054-6063.
135. Wieland S., Belluzzi J.D., Stein L., Lan N.C. Comparative behavioral characterization of the neuroactive steroids 3α-OH,5α-pregnan-20-one and 3α-OH,5β-pregnan-20-one in rodents. Psychopharmacology 1995, 118:65-71.
136. Wohlfarth K.M., Bianchi M.T., Macdonald R.L. Enhanced neurosteroid potentiation of ternary GABAA receptors containing the δ-subunit. J. Neurosci. 2002, 22:1541-1549.
137. Wong M., Moss R.L. Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels. J. Neuroendocrinol. 1994, 6:347-355.
138. Woolley C.S., McEwen B.S. Estradiol regulates hippocampal dendritic spine density via an N-methyl-d-aspartate receptor-dependent mechanism. J. Neurosci. 1994, 14:7680-7687.
139. Woolley C.S., Weiland N.G., McEwen B.S., Schwartzkroin P.A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 1997, 17:1848-1859.
140. A receptor-mediated tonic inhibition and limbic epileptogenesis. J. Pharmacol. Exp. Ther. 2013, 346:146-160.
141. A receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J. Neurosci. 2007, 27:7520-7531.